Mercy Maina gets a shout out from Ivanka Trump
Dr Mercy Maina getting a shout out from Ivanka Trump at the Mandela Washington Fellowship Summit, Washington DC. https://youtu.be/RMhfdE9zeCc…
Dr Mercy Maina getting a shout out from Ivanka Trump at the Mandela Washington Fellowship Summit, Washington DC. https://youtu.be/RMhfdE9zeCc…
The National Science Foundation has awarded our team an exploratory grant to use PADs to detect and dismantle supply chains for bad quality pharmaceuticals. We will work with Professor Karen Smilowitz at Northwestern, who studies logistics and management of health care systems, and with three international partners. Dr. Mercy Maina is a pharmacist at the Moi Teaching and Referral Hospital in Eldoret, Kenya who has a long standing interest in pharmaceutical supply chains, pharmacovigilence, and quality management; Dr. Wasif Ali Khan is a research scientist at the Institute for the study of Diarrheal Diseases, Bangladesh, which has research centers in rural Bangladesh where the bulk of the population lives, and Mr. Ibrahim Chikowe is an instructor in the College of Medicine, University of Malawi. …
Check out the NPR interview with Muhammad Zaman about his book "Bitter Pills: The Global War on Counterfeit Drugs". He is the BU prof who developed a portable dissolution testing device
This review was written by the Nepal/St Mary's team:
Our proposal titled "The whole world is watching: tracking bad quality medicine with citizen science and an electronic ledger" was funded by the Notre Dame Blockchain Working Group for 2018! Computer scientists James and Chris Sweet will work with the PAD project to institute a distributed electronic ledger that can track test results for particular products. We look forward to using this new methodology for determining the reliability of different actors in the pharmaceutical supply chain. …
Notre Dame has licensed the PAD technology to Veripad, LLC. This startup company has developed a cell-phone based PAD reader that automatically analyzes the PAD image for the user. Watch for more developments!
Veripad's mobile application reads the result from the PAD test…
PBS Newshour for Dec. 14 included an 8 min segment on falsified and substandard medicines in Kenya. Mercy Maina (Pharmacist at Moi Teaching and Referral Hospital) appears on this segment to demo some PADs and discuss the public health problems caused by falsified antibiotics. Congrats on the coverage! …
Congratulations to the Veripad team, which received $50K in equity-free support from this round of the Mass Challenge accelerator program. This award will be matched 1:1 by funds from Grand Challenges Canada through its Transition to Scale program with the University of Notre Dame, "Got Fakes?". …
Veripad is a startup company that uses PAD technology and a cell phone reader app to detect suspicious pharmaceuticals. They were just selected to compete for a share of $USD 1.5 million in the Mass Challenge Accelerator program. …
Milk is an important food for people in many countries, but adulteration is all too common. Suppliers of fraudulent milk might add water to increase the volume of their product, and then put in sugars, urea, or starch to restore the density, taste, and appearance of the milk. In a recent publication…
Laboratory Equipment put together a nice piece on the PAD project, featuring Toni Barstis's team at Saint Marys College and Veripad. …
Under the guidance of Prof. Toni Barstis, students from Saint Marys College are using PADs to test drug quality in Nepal.
…
Sandipan Banerjee has been training a neural network to recognize the color signatures from different types of pharmaceuticals. The program is nearly as accurate as human readers.
…
We're excited to be named as a finalist for the Round 7 Saving Lives at Birth seed award. Our innovation wll help birth attendants to treat bleeding after childbirth with high quality medicines that can save lives.
When kids don't get enough iodine in their diet, growth and brain development are stunted. We developed a paper test card to help medical authorities and nutrition specialists monitor the need for iodine supplements in different populations.
Full details are available open access at PLOS-ONE
PAD commercialization takes another step towards reality. Veripad joins 127 other startup companies in this prestigious startup accelerator's 2017 class. Over 5,000 applications were evaluated. In addition to support and mentoring, the team will have access to a premium makerspace and research lab that will be a great starting point for manufacturing prototyping and lane chemistry development. …
Hesburgh Libraries and the Center for Research Computing convened a workshop May 1 and 2, 2017, to discuss how libraries can faciliate preservation and sharing of data. These tasks are more and more important for researchers in the digital age. Margaret Berta gave a nice example of how her research uses Open Science Framework to enable students at 18 different institutions to collaborate on pharmaceutical analysis problems. The electronic site is used to distribute shared experimental protocols, upload electronic lab notebooks, review results and calculations in a secure and private manner, and archive data and workflows for publication. …
Chemistry graduate student Sarah Bliese plans to make a difference in the health of people all over the world through her 2017 Naughton Graduate Fellowship. Air pollutants cause thousands of deaths each year. However, in much of the developing world, technological infrastructure for collecting even basic measurements about air quality is absent, so regulators have little to act upon. Only 10 of the 47 countries in sub-Saharan Africa have even a single air quality monitoring station reporting to WHO today. Sarah will develop and test a new type of sensor network. The network uses small numbers of sensor pods to calibrate hundreds of inexpensive paper test cards that can be deployed by citizen scientists--even by high school students.
Dr. Sergio Caroli presented the PAD card in a post-doctoral level training course on April 6, 2017. The training course was sponsored by the Istituto Superiore di Sanità, the Italian equivalent of the National Institutes of Health.
PAD reveals unexpected filler in Coartem antimalarial product…